info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
Indian Flag  IN: +91-826-083-6500
Home » therapeutics

therapeutics

LAG-3 Targeting Therapy Market By Therapy Type (Monotherapy, Combination Therapy); By Indication (Melanoma, Non-Small Cell Lung Cancer, Triple-Negative Breast Cancer, Head & Neck Squamous Cell Carcinoma, Other Solid Tumors, Hematologic Malignancies); By End User (Hospitals, Specialty Cancer Centers, Academic Research Institutes, Clinical Trial Sites); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global LAG-3 Targeting Therapy Market will witness a strong CAGR of 24.1%, valued at an estimated USD 1.37 billion in 2024 and projected to exce... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

PRMT5 Targeted Therapies Market By Drug Type (Small Molecule Inhibitors, Allosteric Inhibitors, Protein Degraders); By Application (NSCLC, Glioblastoma, Pancreatic Cancer, Mantle Cell Lymphoma, AML, MDS); By Route of Administration (Oral, Intravenous); By End User (Academic Cancer Centers, Oncology Clinics, Community Hospitals, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global PRMT5 Targeted Therapies Market is poised to expand at a robust CAGR of 28.4%, valued at approximately USD 412 million in 2024, and proje... Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

CD39 Targeted Therapies Market By Drug Type (Monoclonal Antibodies, Small Molecule Inhibitors); By Therapeutic Application (Oncology, Autoimmune Disorders, Combination Therapy); By Route of Administration (Intravenous, Subcutaneous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD39 Targeted Therapies Market is projected to expand at a CAGR of 16.8%, rising from USD 427.0 million in 2024<... Read More

Published Date: DEC-2025 | No Of Pages:157 | $ 4485

Biotherapeutics Market By Product Type (Monoclonal Antibodies, Recombinant Proteins, Cell Therapy Products, Gene Therapies, Vaccines); By Application (Oncology, Autoimmune Diseases, Rare Genetic Disorders, Infectious Diseases, Neurological Disorders); By Route of Administration (Intravenous, Subcutaneous, Oral & Others); By End User (Academic & Specialty Hospitals, General Hospitals, Infusion Clinics, Specialty Pharmacies & Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Biotherapeutics Market is projected to grow from USD 356.7 billion in 2024 to nearly USD 587.2 billion by 2030 at a steady 8.6% CAGR, driven by advances i... Read More

Published Date: DEC-2025 | No Of Pages:193 | $ 4485

Hormonal Contraceptives Market By Product Type (Combined Hormonal Contraceptives, Progestin-Only Contraceptives); By Route of Administration (Oral, Transdermal, Subdermal, Intramuscular, Vaginal); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hormonal Contraceptives Market is projected to grow from $21.3 billion in 2024 to $29.7 billion by 2030, expanding at a 5.7% CAGR, driven by rising LARC a... Read More

Published Date: DEC-2025 | No Of Pages:160 | $ 4485

Tumor Infiltrating Lymphocytes (TILs) Market By Therapy Type (Autologous TILs, Genetically Modified TILs); By Indication (Melanoma, NSCLC, Cervical Cancer, Head & Neck Cancer, Others); By Manufacturing Model (Centralized, Decentralized); By End User (Academic Centers, Oncology Hospitals, Cell Therapy Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Tumor Infiltrating Lymphocytes (TILs) Market is projected to reach USD 1.26 billion in 2024 and grow to USD 3.47 billion by 2030 at a robust 18.5% CAGR, d... Read More

Published Date: DEC-2025 | No Of Pages:174 | $ 4485

Venous Thromboembolism (VTE) Treatment Market By Product Type (Anticoagulants, Thrombolytic Agents, Mechanical Thrombectomy Devices, Vena Cava Filters); By Route of Administration (Oral, Injectable, Intravenous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Venous Thromboembolism (VTE) Treatment Market is projected to grow at a steady 6.5% CAGR, rising from USD 10.8 billion in 2024 to nearly USD 16.5 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:175 | $ 4485

Mitochondrial Disease Therapies Market By Therapy Type (Small Molecules, Gene Therapy, Enzyme Replacement, Others); By Route of Administration (Oral, Injectable/Intravenous, Others); By End User (Hospitals, Specialty Clinics, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Mitochondrial Disease Therapies Market will expand steadily at an CAGR of 9.1%, valued at USD 1.1 billion in 2024, and projected to reach USD 2.0 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:188 | $ 4485

Pulmonary Embolism Therapeutics Market By Drug Class (DOACs, LMWH, Unfractionated Heparin, Vitamin K Antagonists, Thrombolytics); By Route of Administration (Oral, Injectable); By Disease Severity (Low-Risk, Submassive, Massive); By End User (Hospitals, Specialty Clinics, Retail Pharmacies, Home Healthcare Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pulmonary Embolism Therapeutics Market is projected to grow at a CAGR of 6.3% , valued at USD 2.7 billion in 2024 and anticipated to reach approximately USD 4.1 bi... Read More

Published Date: DEC-2025 | No Of Pages:155 | $ 4485

Dimpleplasty Market By Procedure Type (Suturing Technique, Excisional Technique); By Gender (Male, Female); By Age Group (18–25, 26–35, 36–50, 50+); By End User (Cosmetic Surgery Clinics, Aesthetic Dermatology Practices, Hospital-Based Cosmetic Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Dimpleplasty Market is projected to grow at a steady CAGR of 9.6% , valued at USD 74.6 million in 2024 and expected to surpass US... Read More

Published Date: DEC-2025 | No Of Pages:172 | $ 4485

Brachioplasty Market By Technique (Traditional Brachioplasty, Mini Brachioplasty, Extended Brachioplasty, Non-Invasive Techniques); By Gender (Male, Female); By End User (Hospitals, Ambulatory Surgical Centers, Aesthetic Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Brachioplasty Market will witness a solid CAGR of 8.2% , valued at USD 1.3 billion in 2024 , and projected to reach USD 2.1 billion by 2030 , according to... Read More

Published Date: DEC-2025 | No Of Pages:173 | $ 4485

Neoantigen Targeted Therapy Market By Therapy Type (Personalized Neoantigen Vaccines, T-cell Based Therapies); By Cancer Indication (Melanoma, NSCLC, Glioblastoma, Bladder Cancer, Colorectal Cancer, Others); By Delivery Platform (mRNA, Peptide, Dendritic Cell, DNA-based); By End User (Academic Medical Centers, Specialty Cancer Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Neoantigen Targeted Therapy Market is projected to expand at a remarkable growth rate, estimated at USD 1.9 billion in 2024 and expected to reach USD 8.5 billion by 2030, ... Read More

Published Date: DEC-2025 | No Of Pages:184 | $ 4485

Theranostics Market By Therapeutic Area (Oncology, Neurology, Cardiology, Others); By Technology Platform (Radiopharmaceuticals, Nanoparticle Systems, Antibody-Drug Conjugates, RNA-Based Platforms); By End User (Academic & Research Institutions, Specialty Clinics, Tertiary Hospitals, CDMOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Theranostics Market is poised for strong growth between 2024 and 2030, with a projected CAGR of 10.4% , growing from USD 13.6 billion in 2024Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

Non-Muscle Invasive Bladder Cancer (NMIBC) Market By Therapy Type (Intravesical Therapy, Immuno-Oncology Agents, Surgery & Resection [TURBT], Emerging Therapies); By Route of Administration (Intravesical, Intravenous/Oral); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Non-Muscle Invasive Bladder Cancer (NMIBC) Market is expected to grow steadily at a CAGR of 6.8%, expanding from USD 2.9 billion in 2024 to around USD 4.3 billion ... Read More

Published Date: DEC-2025 | No Of Pages:159 | $ 4485

Cancer Metabolism Based Therapeutics Market By Therapeutic Class (Enzyme Inhibitors, Immunometabolism Modulators, Multi-Pathway Inhibitors); By Cancer Type (Glioblastoma, Pancreatic Cancer, Acute Myeloid Leukemia, Renal Cell Carcinoma, Non-Small Cell Lung Cancer); By Route of Administration (Oral, Intravenous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cancer Metabolism Based Therapeutics Market is expected to grow at a CAGR of 10.8% , reaching a projected value of $6.7 billion by 2030 , up from $3.5 billion in 2... Read More

Published Date: DEC-2025 | No Of Pages:179 | $ 4485

Functional Endoscopic Sinus Surgery (FESS) Market By Product Type (Endoscopes, Powered Surgical Instruments, Balloon Dilation Systems, Navigation Systems); By Indication (Chronic Rhinosinusitis, Nasal Polyposis, Fungal Sinusitis & Tumors); By End User (Hospitals, ENT Clinics & Specialty Centers, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Functional Endoscopic Sinus Surgery (FESS) Market is projected to grow at a CAGR of 6.8% , with an estimated valuation of USD 3.5 billion in 2024<... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

Allogeneic Cell Therapy Market By Cell Type (Hematopoietic Stem Cells, Mesenchymal Stem Cells, NK Cells, T Cells, Others); By Therapeutic Application (Oncology, Neurology, Autoimmune Disorders, Cardiovascular, Orthopedics, Others); By Source (Bone Marrow, Peripheral Blood, Umbilical Cord Blood, iPSCs); By End User (Hospitals & Specialty Clinics, Academic & Research Institutes, Biopharma & CMOs, Regenerative Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Allogeneic Cell Therapy Market is projected to accelerate at a healthy CAGR of around 18.5%, growing from USD 4.7 billion in 2024 to USD 13.2 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:187 | $ 4485

Novel T-Cell Immunotherapy Market By Therapy Type (CAR-T Cell Therapy, TCR-T Cell Therapy, Tumor-Infiltrating Lymphocytes, Allogeneic T-Cell Therapy); By Indication (Hematologic Malignancies, Solid Tumors, Autoimmune Disorders); By Cell Source (Autologous, Allogeneic); By End User (Academic & Research Institutes, Specialty Cancer Centers, CDMOs, Community Oncology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Novel T-Cell Immunotherapy Market is poised for rapid expansion, valued at USD 6.8 billion in 2024 and projected to reach USD 18.9 billion by 2030 , growi... Read More

Published Date: DEC-2025 | No Of Pages:168 | $ 4485

Vascular Disrupting Agents (VDA) Market By Type of Agent (Tubulin-Binding Agents, Non-Tubulin-Binding Agents); By Cancer Indication (Non-Small Cell Lung Cancer, Ovarian Cancer, Colorectal Cancer, Head and Neck Squamous Cell Carcinoma, Sarcomas); By Route of Administration (Intravenous, Intratumoral); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Vascular Disrupting Agents (VDA) Market is anticipated to expand at a CAGR of 8.5%, moving from USD 1.9 billion in 2024 to nearly USD 3.3 billion by 2030,... Read More

Published Date: DEC-2025 | No Of Pages:164 | $ 4485

DNA Damage Response (DDR) Market By Therapeutic Class (PARP Inhibitors, ATM/ATR Inhibitors, WEE1 Inhibitors, CHK1/CHK2 Inhibitors, POLQ and Others); By Indication (Ovarian Cancer, Breast Cancer, Prostate Cancer, Pancreatic Cancer, Others); By End User (Academic & Research Institutes, Cancer Hospitals, Private Oncology Clinics, Diagnostic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global DNA Damage Response (DDR) Market is projected to grow steadily, with an estimated value of USD 5.8 billion in 2024 and forecasted to reach USD 11.2 billion by 2030... Read More

Published Date: DEC-2025 | No Of Pages:152 | $ 4485

Peripheral Neuropathy Treatment Market By Treatment Type (Pharmacological Therapies, Medical Devices, Complementary Interventions); By Indication (Diabetic Neuropathy, Chemotherapy-Induced Neuropathy, Post-Herpetic Neuralgia, Alcohol-Related Neuropathy, Idiopathic Neuropathy); By Route of Administration (Oral, Topical, Device-Based); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Homecare & Telehealth); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Peripheral Neuropathy Treatment Market will witness a steady CAGR of 6.8% , valued at USD 2.47 billion in 2024 , and projected to reach USD 3.68 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:178 | $ 4485

Joint Pain Injections Market By Product Type (Corticosteroid Injections, Hyaluronic Acid Injections, PRP Injections, Stem Cell-Based Injections, Combination & Other Biologics); By Joint/Application (Knee, Hip, Shoulder, Ankle, Elbow, Others); By End User (Hospitals, Orthopedic Clinics, ASCs, Sports Medicine & Rehab Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Joint Pain Injections Market is projected to grow at a CAGR of 6.8% , reaching approximately USD 8.1 billion in 2030 , up from an estimated USD 5.... Read More

Published Date: DEC-2025 | No Of Pages:190 | $ 4485

Non-Hormonal Contraceptives Market By Product Type (Barrier Methods, Copper IUDs, Spermicides & Vaginal Gels, Fertility Awareness & Digital Tools); By Distribution Channel (Hospitals & Clinics, Retail Pharmacies & Drugstores, Online Platforms); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Non-Hormonal Contraceptives Market is projected to expand steadily between 2024 and 2030, with an estimated valuation of USD 8.7 billion in 2024 and expected to reach arou... Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

TCR Therapy Market By Target Antigen Type (Cancer-Testis Antigens, Neoantigens, Viral Antigens); By Indication (Synovial Sarcoma, Non-Small Cell Lung Cancer, Ovarian Cancer, Colorectal Cancer, Others); By Technology Platform (Naturally Derived TCRs, Affinity-Enhanced TCRs, Gene-Edited TCRs, Allogeneic TCR T cells); By End User (Academic Cancer Centers, Specialized Immunotherapy Clinics, Tertiary Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global TCR Therapy Market will surge at a remarkable CAGR of 38.4%, reaching USD 8.9 billion by 2030 from USD 0.9 billion in 2024, driven by cancer immun... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

Sciatica Treatment Market By Treatment Type (Drug Therapy, Physical Therapy & Rehabilitation, Interventional Procedures, Surgical Interventions, Alternative Therapies); By Route of Administration (Oral, Injectable, Topical, Transdermal); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Pain Clinics, Rehabilitation Centers, Homecare & Digital Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Sciatica Treatment Market is forecast to grow at a steady CAGR of 5.4%, valued at USD 7.8 billion in 2024 and projected to reach nearly USD 10.7 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:162 | $ 4485

Short Bowel Syndrome Market By Drug Class (GLP-2 Analogues, Growth Hormones, Antidiarrheals, Proton Pump Inhibitors, Others); By Route of Administration (Parenteral, Oral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Short Bowel Syndrome Market is anticipated to grow at a CAGR of 8.7 %, valued at USD 1.62 billion in 2024 and projected to reach USD 2.71 billion by 2030,... Read More

Published Date: DEC-2025 | No Of Pages:192 | $ 4485

Neovaginal Surgery Market By Surgical Technique (Penile Inversion, Sigmoid Colon, Peritoneal, Skin/Buccal Graft); By Indication (Gender-Affirming Surgery, Congenital Anomalies, Reconstructive Oncology/Trauma); By End User (Academic Medical Centers, Specialty Clinics, Public Hospitals, Congenital Care Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Neovaginal Surgery Market Is projected to grow at a robust CAGR of 9.8% , reaching a total market value of approximately USD 3.2 billion in 2030 , up from... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

Appendicitis Treatment Market By Treatment Type (Open Appendectomy, Laparoscopic Appendectomy, Robotic-Assisted Appendectomy, Non-Surgical Antibiotic Therapy); By Route of Administration (Intravenous, Oral, Parenteral); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Appendicitis Treatment Market will witness a steady CAGR of 7.6%, valued at USD 7.8 billion in 2024 and expected to reach USD 12.... Read More

Published Date: DEC-2025 | No Of Pages:153 | $ 4485

Biofilms Treatment Market By Product Type (Topical Agents, Enzymatic Disruptors, Systemic Antibiotics, Surface Coatings, Novel Therapeutics); By Application (Chronic Wounds, Orthopedic Implant Infections, Cardiovascular Devices, Dental & Oral Health, Urology); By End User (Hospitals & Surgical Centers, Wound Care Clinics, Dental Clinics, Veterinary & Military Care); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Biofilms Treatment Market is projected to grow at a CAGR of 8.6% between 2024 and 2030. The market is estimated to be worth USD 3.1 billion in 2024 and is... Read More

Published Date: DEC-2025 | No Of Pages:189 | $ 4485

Leptospirosis Market By Product Type (Diagnostics, Therapeutics, Vaccines); By Application (Human Health, Animal Health); By End User (Hospitals & Clinics, Diagnostic Laboratories, Veterinary Clinics & Farms, Public Health Agencies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Leptospirosis Market is projected to register a CAGR of 5.9%, reaching USD 920 million by 2030 from USD 650 million in 2024, supported by antimicr... Read More

Published Date: DEC-2025 | No Of Pages:193 | $ 4485

Cartilage Degeneration Market By Treatment Type (Non-Surgical [Pharmacological, Biologics, Injections], Surgical [Implants, Grafts, Regenerative Therapies]); By Application (Knee, Hip, Ankle, Shoulder, Others); By End User (Hospitals, Specialty Orthopedic & Sports Medicine Clinics, Ambulatory Surgical Centers, Research & Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cartilage Degeneration Market will witness a steady CAGR of 6.8%, valued at USD 9.7 billion in 2024, expected to reach USD 15.3 billion by 2030, according... Read More

Published Date: DEC-2025 | No Of Pages:154 | $ 4485

Gerontology Market By Product & Service Type (Assistive Technologies, Geriatric Pharmaceuticals, Long-Term Care Services, Digital Health & Monitoring Tools, Wellness & Preventive Services); By Application (Chronic Disease Management, Cognitive Health and Dementia Care, Mobility and Fall Prevention, Mental Health Support, End-of-Life and Palliative Care, Preventive and Lifestyle Medicine); By End User (Hospitals and Geriatric Clinics, Long-Term Care Facilities, Home-Based Care Settings, Community Health Centers, Individual Consumers and Families); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gerontology Market will witness a steady CAGR of 6.3% , valued at USD 298.7 billion in 2024 , and is projected to reach USD 455.1 billion by 2030 , accord... Read More

Published Date: DEC-2025 | No Of Pages:153 | $ 4485

Lumpectomy Market By Surgery Type (Standard Lumpectomy, Oncoplastic Lumpectomy, Image-Guided Lumpectomy); By Technology Used (Wire Localization, Radiofrequency & Magnetic Seed Localization, Vacuum-Assisted Excision Devices); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Cancer Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lumpectomy Market will witness a steady CAGR of 6.1%, valued at USD 2.3 billion in 2024 , expected to appreciate and reach USD 3.3 billion by 2030, confir... Read More

Published Date: DEC-2025 | No Of Pages:179 | $ 4485

Dupixent Market By Indication (Atopic Dermatitis, Asthma, Chronic Rhinosinusitis with Nasal Polyps, Eosinophilic Esophagitis, Prurigo Nodularis); By Age Group (Adults, Adolescents, Pediatrics); By Delivery Mode (Prefilled Syringes, Auto-injectors); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dupixent Market is projected to grow at a compound annual growth rate (CAGR) of 13.8% , with an estimated value of USD 9.8 billion in 2024Read More

Published Date: DEC-2025 | No Of Pages:164 | $ 4485

Lysosomal Storage Disease Treatment Market By Disease Type (Gaucher Disease, Fabry Disease, Pompe Disease, Mucopolysaccharidoses, Niemann-Pick Disease, Others); By Treatment Type (Enzyme Replacement Therapy, Substrate Reduction Therapy, Pharmacological Chaperones, Gene Therapy); By Route of Administration (Intravenous, Oral); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Home Infusion Services); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lysosomal Storage Disease ( LSD ) Treatment Market will witness a robust CAGR of 9.1%, valued at approximately USD 2.3 billion in 2024 an... Read More

Published Date: DEC-2025 | No Of Pages:155 | $ 4485

Diabetic Ketoacidosis Treatment Market By Treatment Type (Insulin Therapy, Fluid & Electrolyte Replacement, Adjunctive Therapies, Glucose Monitoring); By Route of Administration (Intravenous, Subcutaneous, Oral); By End User (Hospitals, Emergency Departments, Ambulatory Care Centers, Diabetes Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Diabetic Ketoacidosis Treatment Market is projected to grow from USD 3.6 billion in 2024 to USD 5.2 billion by 2030, registering a 6.4% CAGR, driven by ri... Read More

Published Date: DEC-2025 | No Of Pages:187 | $ 4485

Binge-Eating Disorder Treatment Market By Treatment Type (Pharmacotherapy, Cognitive Behavioral Therapy, Digital Therapeutics, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By End User (Hospitals, Specialty Clinics, Outpatient Therapy Centers, Digital Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Binge - Eating Disorder Treatment Market will expand at a CAGR of 6.8% , valued at USD 520 million in 2024 and projected... Read More

Published Date: DEC-2025 | No Of Pages:157 | $ 4485

Tremfya (Guselkumab) Market By Product Type (Injectable Biologic); By Application (Plaque Psoriasis, Psoriatic Arthritis, Pipeline Indications – Crohn’s Disease, Ulcerative Colitis); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Retail & Specialty Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Tremfya (Guselkumab) Market is forecast to expand at a CAGR of 9.1%, valued at USD 3.1 billion in 2024 and reaching nearly USD 5.8 billion by 2030, driven... Read More

Published Date: DEC-2025 | No Of Pages:196 | $ 4485

Naltrexone and Buprenorphine Market By Product Type (Naltrexone, Buprenorphine); By Route of Administration (Oral, Transdermal/Implants, Injectables); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Naltrexone and Buprenorphine Market will witness a steady CAGR of 6.8% , valued at around USD 3.6 billion in 2024 , and projected to reach USD 5.4 billion by 2030<... Read More

Published Date: DEC-2025 | No Of Pages:186 | $ 4485

Cyclosporine Market By Therapeutic Application (Transplantation, Autoimmune Disorders, Ophthalmology); By Formulation Type (Oral Capsules, Injectables, Topical Formulations); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cyclosporine Market will see consistent expansion at a CAGR of 6.1%, rising from USD 1.53 billion in 2024 to USD 2.19 billion by 2030, supported by strong... Read More

Published Date: DEC-2025 | No Of Pages:160 | $ 4485

Thoracic Aortic Aneurysm Market By Product Type (Stent Grafts, Synthetic Grafts, Surgical Instruments, Imaging Systems); By Approach (Endovascular Repair [TEVAR], Open Surgical Repair); By Indication (Ascending Aortic Aneurysms, Descending Thoracic Aneurysms, Thoracoabdominal Aneurysms); By End User (Hospitals, Specialty Cardiac Centers, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Thoracic Aortic Aneurysm Market is set to witness stable expansion at a CAGR of 8.4%, increasing from USD 2.5 billion in 2024 to USD 4.1 billion by 2030, ... Read More

Published Date: DEC-2025 | No Of Pages:177 | $ 4485

Anti-Biofilm Wound Dressing Market By Product Type (Foam Dressings, Hydrofiber Dressings, Alginate Dressings, Combination Dressings); By Wound Type (Chronic Wounds, Acute Wounds); By End User (Hospitals, Specialty Wound Care Clinics, Ambulatory Surgical Centers, Home Healthcare, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Anti-Biofilm Wound Dressing Market is set to grow at a sustained CAGR of 6%, climbing from USD 790 million in 2024 to more than USD 1.1 billion by 2030, p... Read More

Published Date: DEC-2025 | No Of Pages:193 | $ 4485

Male Urinary Incontinence Market By Product Type (Catheters, Artificial Urinary Sphincters, Male Slings, Absorbent Products, External Clamps); By Application (Stress Incontinence, Urge Incontinence, Overflow Incontinence, Mixed Incontinence); By End User (Hospitals, Specialty Urology Clinics, Ambulatory Surgical Centers, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Male Urinary Incontinence Market will witness a CAGR of 6.8%, valued at USD 3.4 billion in 2024 , expected to appreciate and reach nearly USD 5.1 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

Hemangioma Treatment Market By Therapy Type (Pharmacological Therapy, Laser Therapy, Surgical and Interventional Approaches); By Application (Cutaneous Hemangiomas, Visceral Hemangiomas, Mixed and Complicated Hemangiomas); By End User (Hospitals, Specialty Dermatology and Pediatric Clinics, Ambulatory Surgical Centers, Community Health Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hemangioma Treatment Market will grow at a CAGR of 6.8% , valued at USD 4.9 billion in 2024 , and projected to reach USD 7.7 bill... Read More

Published Date: DEC-2025 | No Of Pages:197 | $ 4485

Drug Repurposing Market By Therapeutic Area (Oncology, Neurology, Infectious Diseases, Cardiovascular, Autoimmune Disorders); By Drug Type (Generic Drugs, Off-Patent Drugs, Patented Drugs); By End User (Pharmaceutical Companies, Academic and Research Institutes, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Drug Repurposing Market will witness a robust CAGR of 7.6% , valued at USD 32.4 billion in 2024 , expected to appreciate and reach USD 50.3 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:168 | $ 4485

Peripheral Artery Disease (PAD) Market By Treatment Type (Pharmacological, Surgical, Endovascular); By Diagnostic Modality (ABI Testing, Ultrasound, CTA, MRA); By End User (Hospitals, Diagnostic Imaging Centers, ASCs, General Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Peripheral Artery Disease (PAD) Market will witness steady expansion at a CAGR of 6.3% from 2024 to 2030, rising from USD 6.5 billion in 2024 to USD 10.2 billion b... Read More

Published Date: NOV-2025 | No Of Pages:191 | $ 4485

Adult Intraventricular Hemorrhage (IVH) Market By Diagnostic Modality (CT, MRI, Ultrasound); By Treatment Type (Surgical Intervention, Pharmaceutical Treatment, Rehabilitation Therapy); By End User (Hospitals, Rehabilitation Centers, Trauma Centers, Specialized Stroke Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Adult Intraventricular Hemorrhage (IVH) Market is projected to grow steadily, with an estimated value of USD 1.8 billion in 2024 , expected to reach Read More

Published Date: NOV-2025 | No Of Pages:173 | $ 4485

Light Therapy Market By Device Type (Full-body Light Boxes, Portable Devices, Wearable Units); By Application (Dermatology, Seasonal Affective Disorder, Neurological Rehabilitation, Sleep Disorders, Wound Healing); By End User (Hospitals & Clinics, Dermatology & Aesthetic Centers, Wellness Centers & Spas, Home Users); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Light Therapy Market, valued at USD 1.2 billion in 2024, is expected to grow at a steady CAGR of 5.8%, reaching USD 1.68 billion by 2030, driven by i... Read More

Published Date: NOV-2025 | No Of Pages:178 | $ 4485

Orthobiologics Market By Product Type (Stem Cells, PRP, Growth Factors, Bone Grafts); By Application (Orthopedic Conditions, Sports Medicine, Spinal Surgery); By End User (Hospitals, ASCs, Specialized Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Orthobiologics Market is projected to grow from USD 7.1 billion in 2024 to USD 12.2 billion by 2030 at a CAGR of 8.4%, driven by rising demand for regenerative therapies, stem cell treatme... Read More

Published Date: NOV-2025 | No Of Pages:157 | $ 4485

Breast Conserving Surgery Market By Surgical Technique (Traditional, Robotic-Assisted, IORT, Partial Breast Radiation); By End-User (Hospitals, Oncology Clinics, ASCs, Diagnostic Imaging Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Breast Conserving Surgery (BCS) Market is valued at USD 4.7 billion in 2024 and projected to grow at a 5.1% CAGR, reaching USD 7.7 billion by 2030, driven... Read More

Published Date: NOV-2025 | No Of Pages:177 | $ 4485

Dermal Regeneration Market By Product Type (Stem Cell Therapies, Growth Factor Therapies, Skin Substitutes, Wound Dressings); By Application (Burns, Chronic Wounds, Cosmetic Dermatology); By End User (Hospitals, Specialty Clinics, Home Healthcare, Rehabilitation Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dermal Regeneration Market is projected to reach USD 9.7 billion in 2024 and grow at a robust 8.5% CAGR to USD 16.4 billion by 2030, driven by rising chro... Read More

Published Date: NOV-2025 | No Of Pages:156 | $ 4485

Circadian Rhythm Sleep Disorder Market By Disorder Type (Delayed Sleep Phase Disorder, Shift Work Sleep Disorder, Non-24-Hour Sleep-Wake Disorder, Advanced Sleep Phase Disorder, Jet Lag Disorder); By Treatment Type (Pharmacological, Light Therapy, Digital Therapeutics, Wearables); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online); By End User (Sleep Clinics, General Hospitals, Employers, Consumers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Circadian Rhythm Sleep Disorder Market is projected to reach USD 3.9 billion by 2030 from USD 2.2 billion in 2024, expanding at a CAGR of 9.5%, drive... Read More

Published Date: NOV-2025 | No Of Pages:183 | $ 4485

Immuno-Oncology Antibodies Market By Therapy Type (Monoclonal Antibodies, Bispecific Antibodies, IO-Active ADCs, CAR-T, TCR-T, NK & γδ-T Cell Therapies); By Cancer Type (Solid Tumors, Hematologic Malignancies); By Line of Therapy (First-Line, Second-Line, Later-Line); By Biomarker Class (PD-L1, MSI-H/dMMR, HER2, BCMA, GPRC5D, CLDN18.2 and Others); By Geography (United States, Europe, Asia-Pacific, Latin America), Segment Revenue Estimation & Forecast, 2025–2035

1. Introduction & Strategic Context

The Global Immuno-Oncology market for monoclonal antibodies & cell therapies expands from USD 55–60B in 2025 to ~USD 140B by 2035, propelled by deeper first-line penetration of PD-1/PD... Read More

Published Date: NOV-2025 | No Of Pages:180 | $ 4485

Endometriosis and Uterine Fibroid Therapeutics Market By Therapy Type (Combined Oral Contraceptives, Progestogens & LNG-IUS, GnRH Agonists, Oral GnRH Antagonists, Emerging Non-Hormonal Therapies); By Disease Type (Endometriosis, Uterine Fibroids); By Distribution Channel (Hospitals & Surgical Centers, Specialty Gynecology Clinics, Retail & Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2025–2035.

1. Introduction and Strategic Context

The Global Endometriosis & Uterine Fibroid Therapeutics Market is entering a decade of accelerated growth, expanding from USD 1.60 billion in 2025 to USD 5.50 billion by 2035,... Read More

Published Date: NOV-2025 | No Of Pages:180 | $ 5485

Hadron Therapy Market By Treatment Type (Proton Therapy, Heavy Ion Therapy, Other Emerging Therapies); By Technology (Particle Accelerators, Treatment Planning Systems); By End User (Hospitals & Cancer Treatment Centers, Research & Academic Institutions, Contract Research Organizations, Government & Regulatory Bodies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hadron Therapy Market is poised for steady growth, with a projected CAGR of 7.3% from 2024 to 2030, expected to increase from USD 3.1 billion in 2024 to <... Read More

Published Date: NOV-2025 | No Of Pages:182 | $ 4485

Long-Acting Injectables (LAIS) Market By Product Type (Injectable Depot Formulations, Implantable LAIs); By Therapeutic Application (Psychiatric Disorders, HIV Treatment, Chronic Pain Management, Endocrine Disorders, Others); By End-User (Hospitals, Clinics, Specialty Pharmacies, Contract Research Organizations, Primary Care Physicians); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Long-Acting Injectables (LAIS) Market is set to witness a significant rise, driven by increasing demand for advanced therapies with better patient compliance and reduced frequency of administration. Valued at Read More

Published Date: NOV-2025 | No Of Pages:181 | $ 4485

Spinal Cord Injury (SCI) Treatment Market By Treatment Type (Pharmaceuticals, Medical Devices, Stem Cell Therapies, Rehabilitation Technologies); By End User (Hospitals, Rehabilitation Centers, Home Care, CROs); By Region (North America, Europe, Asia-Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Spinal Cord Injury (SCI) Treatment Market is projected to grow at a 7.4% CAGR, rising from USD 7.5 billion in 2024 to USD 12.1 billion by 2030, driven by advancements in n... Read More

Published Date: NOV-2025 | No Of Pages:176 | $ 4485

Cutaneous T-cell Lymphoma (CTCL) Market By Treatment Modality (Immunotherapy, Chemotherapy, Phototherapy, Topical Therapies); By Distribution Channel (Hospitals, Clinics, Pharmacies & Online); By End User (Oncology Hospitals, Private Clinics, Research Institutions, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cutaneous T-Cell Lymphoma (CTCL) Market is projected to grow from USD 1.3 billion in 2024 to USD 2.5 billion by 2030, at a CAGR of 8.5%, driven by advance... Read More

Published Date: NOV-2025 | No Of Pages:180 | $ 4485

Movement Disorder Market By Disease Type (Parkinsons Disease, Essential Tremor, Dystonia, Huntingtons Disease); By Treatment Modality (Pharmacological, Surgical, Gene Therapy, Physical Therapy); By End-User (Hospitals & Clinics, Home Care Settings, Research Institutes, CROs); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Movement Disorder Market is valued at USD 7.5 billion in 2024 and is projected to grow at a CAGR of 8.5%, reaching USD 13.5 billion by 2030, driven by ris... Read More

Published Date: NOV-2025 | No Of Pages:183 | $ 4485

Bone Marrow Aspirate Concentrates (BMAC) Market By Product Type (Aspiration Kits, Concentrators & Processing Equipment); By Application (Orthopedics & Musculoskeletal Disorders, Cardiovascular Diseases, Neurological Disorders, Others); By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Research & Academic Institutions, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bone Marrow Aspirate Concentrates (BMAC) Market is valued at USD 2.4 billion in 2024, and is projected to reach USD 5.13 billion by 2030,... Read More

Published Date: NOV-2025 | No Of Pages:161 | $ 4485

Vaginal Rejuvenation Market By Treatment Type (Laser-Based Treatments, Radiofrequency Energy, Surgical Procedures); By Procedure Type (Non-Invasive, Minimally Invasive); By End-User (Cosmetic Clinics, Gynecology Clinics, Hospitals, Medical Spas); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Vaginal Rejuvenation Market is projected to grow at a CAGR of 8.5%, rising from $1.2 billion in 2024 to $2.1 billion by 2030, driven by increasing demand ... Read More

Published Date: NOV-2025 | No Of Pages:179 | $ 4485

Oncology Nutrition Market By Product Type (Oral Nutrition Supplements, Enteral Nutrition Products, Parenteral Nutrition Products, Therapeutic Diets & Nutritional Foods); By Application (Chemotherapy, Radiation Therapy, Surgical Oncology, Immunotherapy); By End-User (Hospitals, Academic & Research Institutions, Contract Research Organizations, Homecare Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Oncology Nutrition Market is projected to witness a robust growth, with a CAGR of 7.5% from 2024, valued at USD 5.6 billion in 2024 , expected to apprecia... Read More

Published Date: NOV-2025 | No Of Pages:174 | $ 4485

Renal Anemia Treatment Market By Product Type (Erythropoiesis-Stimulating Agents [ESAs], Iron Supplements, Vitamin B12 and Folate Supplements); By Treatment Approach (Dialysis-Based, Non-Dialysis CKD Patients); By End User (Hospitals, Dialysis Centers, Specialized Clinics, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Renal Anemia Treatment Market is set to witness significant growth over the forecast period from 2024 to 2030, valued at USD 5.9 billion in 2024 and projected to reach USD 8.7 bill... Read More

Published Date: NOV-2025 | No Of Pages:192 | $ 4485

Small Molecule Targeted Cancer Therapy Market By Therapy Type (Kinase Inhibitors, PARP Inhibitors, Apoptosis Inducers); By Cancer Type (Lung Cancer, Breast Cancer, Melanoma, Colorectal Cancer, Hematologic Cancers, Others); By Route of Administration (Oral, Injectable); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Small Molecule Targeted Cancer Therapy Market will grow at a promising CAGR of 7.3%, valued at $64.5 billion in 2024 and projected to reach $99.6 billion by 2030Read More

Published Date: NOV-2025 | No Of Pages:177 | $ 4485

Neuroprotection Market By Product Type (Drugs, Devices); By Therapeutic Application (Neurodegenerative Diseases, Traumatic Brain Injury, Stroke and Ischemic Disorders); By End User (Hospitals & Clinics, Research Institutions, Contract Research Organizations, Home Care Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Neuroprotection Market is expected to witness significant expansion at a CAGR of 10.4%, rising from USD 5.6 billion in 2024 to USD 10.2 billion by 2030, s... Read More

Published Date: NOV-2025 | No Of Pages:158 | $ 4485

Circadian Rhythm Sleep Treatment Market By Treatment Type (Pharmacological Therapies, Non-Pharmacological Therapies); By Disorder Type (Delayed Sleep Phase Disorder, Advanced Sleep Phase Disorder, Non-24-Hour Sleep-Wake Disorder, Shift Work Sleep Disorder, Jet Lag Disorder); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Circadian Rhythm Sleep Treatment Market will witness a steady CAGR of 6.2%, valued at $1.72 billion in 2024, expected to grow and reach $2.61 billion by 2030Read More

Published Date: NOV-2025 | No Of Pages:187 | $ 4485

Aortic Stenosis Treatment Market By Treatment Type (Surgical Aortic Valve Replacement, Transcatheter Aortic Valve Replacement, Balloon Aortic Valvuloplasty, Medications); By End-User (Hospitals, Specialized Cardiac Clinics, Ambulatory Surgical Centers, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Aortic Stenosis Treatment Market is expected to grow significantly, driven by increasing global awareness of cardiovascular diseases and the growing aging population. In 2024, the market i... Read More

Published Date: NOV-2025 | No Of Pages:162 | $ 4485

Postherpetic Neuralgia (PHN) Treatment Market By Treatment Type (Oral Medications, Topical Treatments, Injectables); By Drug Class (Anticonvulsants, Tricyclic Antidepressants, Opioids, Others); By Region (North America, Europe, Asia Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Postherpetic Neuralgia (PHN) Treatment Market will witness a robust growth with an estimated CAGR of 5.1%Read More

Published Date: NOV-2025 | No Of Pages:166 | $ 4485

Compartment Syndrome Monitoring Market By Product Type (Pressure Monitoring Systems, Wearable Sensors, Diagnostic Kits); By Application (Trauma & Emergency Care, Post-Surgical Monitoring, Military & Field Applications); By End User (Hospitals & Trauma Centers, Ambulatory Surgical Centers, Emergency Medical Services, Military); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Compartment Syndrome Monitoring Market is anticipated to experience a significant growth trajectory, with an expected CAGR of 7.2% , projected to reach Read More

Published Date: NOV-2025 | No Of Pages:150 | $ 4485

Trauma Care Centers Market By Facility Type (Level I, Level II & III, Mobile & Rural Units); By Injury Type (Road Traffic, Falls, Penetrating/Blunt, Burn & Chemical); By End User (Public Hospitals, Private Trauma Facilities, Military & Defense, Academic Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Trauma Care Centers Market will witness a steady CAGR of 6.3% , valued at $24.5 billion in 2024 , expected to appreciate and reach appro... Read More

Published Date: NOV-2025 | No Of Pages:188 | $ 4485

Progressive Multifocal Leukoencephalopathy (PML) Treatment Market By Treatment Type (Drug Therapies, Biologic Treatments); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Region (North America, Europe, Asia Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Progressive Multifocal Leukoencephalopathy (PML) Treatment Market is poised for notable growth, projected to expand at a CAGR of 8.5% from 2024 to 2030, with an estimated market value of <... Read More

Published Date: NOV-2025 | No Of Pages:184 | $ 4485

Bioidentical Hormones Market By Product Type (Hormone Replacement Therapies, Compounded Hormones); By Application (Menopause Treatment, Andropause Treatment, Thyroid Disorders, Other Applications); By End User (Pharmaceutical Companies, Compounding Pharmacies, Wellness Centers, Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Bioidentical Hormones Market is poised for strong growth in the 2024-2030 period, driven by increasing demand for hormone replacement therapies (HRT) that use hormones structurally identical to those the b... Read More

Published Date: NOV-2025 | No Of Pages:165 | $ 4485

Clostridium Difficile Infection Treatment Market By Treatment Type (Antibiotics, Immunotherapies, Microbiota Restoration Therapies, Others); By Route of Administration (Oral, Intravenous, Rectal); By End User (Hospitals, Ambulatory Surgical Centers, Long-Term Care Facilities, Home Healthcare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Clostridium Difficile Infection (CDI) Treatment Market is projected to grow at a CAGR of 5.9%, reaching $2.87 billion by 2030, up from $1.91 billion in 2024Read More

Published Date: NOV-2025 | No Of Pages:155 | $ 4485

Peptide Receptor Radionuclide Therapy (PRRT) Market By Product Type (Radiopharmaceuticals, Peptides); By Application (Neuroendocrine Tumors, Other Cancers); By End-User (Hospitals, Research Institutions, CROs, Imaging Centers); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Peptide Receptor Radionuclide Therapy (PRRT) market is anticipated to experience a notable growth trajectory from 2024 to 2030 , driven by an increasing focus on advanced cancer treatments. The m... Read More

Published Date: NOV-2025 | No Of Pages:164 | $ 4485

Fibroblast Growth Factor Receptor (FGFR) Inhibitor Market By Drug Type (Selective Inhibitors, Pan-FGFR Inhibitors); By Application (Cancer Treatment, Other Therapies); By End User (Hospitals, Cancer Research Institutes, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Fibroblast Growth Factor Receptor ( FGFR ) Inhibitor Market is poised for substantial growth, with a projected Read More

Published Date: NOV-2025 | No Of Pages:163 | $ 4485

Autologous Conditioned Plasma Market By Product Type (Pure PRP Systems, Leukocyte-Rich PRP Systems); By Application (Orthopedic & Sports Injuries, Aesthetic Medicine, Wound Healing, Dental Surgery, Veterinary); By End User (Hospitals, Specialty Clinics, Research Institutes, Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Autologous Conditioned Plasma Market will witness a robust CAGR of 8.86 % , valued at $980 million in 2024 , and is expected to appreciate and reach near... Read More

Published Date: NOV-2025 | No Of Pages:151 | $ 4485

Psychotic Disorder Treatment Market By Drug Class (Atypical Antipsychotics, Typical Antipsychotics, Novel Mechanism Drugs); By Treatment Modality (Pharmacological, Psychotherapy, Digital Therapeutics, Community-Based Programs); By End User (Psychiatric Hospitals, Outpatient Clinics, Community Mental Health Centers, Digital Health Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Psychotic Disorder Treatment Market will witness a moderate but steady CAGR of 5.2%, valued at $13.2 billion in 2024 and expected to reach nearly $18.4 billion by ... Read More

Published Date: NOV-2025 | No Of Pages:169 | $ 4485

Radioimmunotherapy Market By Product Type (Monoclonal Antibodies, Radiopharmaceuticals); By Application (Cancer Treatment, Diagnostic Imaging); By End-User (Hospitals & Oncology Centers, Pharmaceutical & Biotech Companies, Research Institutions, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Radioimmunotherapy Market is set for stable growth at a CAGR of 7.2%, valued at USD 1.6 billion in 2024 and projected to reach USD 2.8 billion by 2030, dr... Read More

Published Date: NOV-2025 | No Of Pages:187 | $ 4485

Triple Negative Breast Cancer Treatment Market By Treatment Type (Chemotherapy, Immunotherapy, Targeted Therapy, Others); By Treatment Setting (Early-Stage, Metastatic/Advanced); By Distribution Channel (Hospitals & Oncology Clinics, Specialty Cancer Centers, Outpatient & Home Care); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Triple Negative Breast Cancer (TNBC) Treatment Market is projected to expand at a steady CAGR of around 8.5%, reaching USD 3.2 billion in 2024 and expected to surpass Read More

Published Date: NOV-2025 | No Of Pages:165 | $ 4485

Alcoholic Hepatitis Treatment Market By Treatment Type (Pharmacological Treatments, Liver Transplantation, Emerging Therapies); By Drug Class (Corticosteroids, Pentoxifylline, Immunosuppressive Drugs); By Route of Administration (Oral, Parenteral); By End-User (Hospitals, Outpatient Clinics, Research Institutes, CROs); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Alcoholic Hepatitis Treatment Market is set to grow rapidly over the forecast period of 2024–2030, driven by rising liver disease, alcohol-related liver dama... Read More

Published Date: NOV-2025 | No Of Pages:182 | $ 4485

Urinary Tract Infection Treatment Market By Drug Type (Quinolones, Beta-lactam & Cephalosporins, Sulfonamides, Tetracyclines, Aminoglycosides, Others); By Clinical Type (Uncomplicated UTI, Complicated UTI, Recurrent UTI, Catheter-Associated UTI); By End User (Hospitals, Retail Pharmacies, Clinics, Online Providers & Telemedicine); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Urinary Tract Infection (UTI) Treatment Market will witness a steady CAGR of 4.6%, valued at $10.4 billion in 2024 and projected to reach $13.6 billion by 2030Read More

Published Date: NOV-2025 | No Of Pages:155 | $ 4485

Transplantation Market By Product Type (Solid Organ Transplants, Bone Marrow Transplants, Corneal Transplants); By Application (End-Stage Organ Failure, Cancer Treatment, Ophthalmic Treatments); By End User (Hospitals & Transplant Centers, Research Institutions, Pharmaceutical Companies, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Transplantation Market will witness a steady compound annual growth rate (CAGR) of 4.5% , valued at USD 22.3 billion in 2024, and is expected to reach USD 29.5 bil... Read More

Published Date: NOV-2025 | No Of Pages:196 | $ 4485

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Treatment Market By Drug Type (Biologics, Immunosuppressants); By Treatment Approach (First-Line Therapies, Second-Line Therapies); By Route of Administration (Intravenous, Subcutaneous); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Treatment Market is poised for steady growth, with the market expected to expand at a CAGR of 5.1% between 2024 and 2030. Valued at... Read More

Published Date: NOV-2025 | No Of Pages:186 | $ 4485

Cardiac Arrest Treatment Market By Product Type (Defibrillators, CPR Devices, Emergency Drugs, Airway Equipment, Circulatory Support); By Treatment (Basic Life Support, Advanced Cardiovascular Life Support, Targeted Temperature Management, Extracorporeal CPR); By End User (Hospitals, EMS, Public Facilities, Military, Ambulatory Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cardiac Arrest Treatment Market is projected to grow at a robust CAGR of 8.4%, valued at $7.8 billion in 2024 and expected to reach $13.5 billion by 2030,... Read More

Published Date: NOV-2025 | No Of Pages:181 | $ 4485

Liver Metastasis Treatment Market By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Surgery); By End User (Hospitals, Oncology Clinics, Research Institutions); By Region (North America, Europe, Asia Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Liver Metastasis Treatment Market is set to experience strong growth, with a CAGR of 8.4% from 2024 to 2030. The market, valued at USD 5.2 billion in 2024... Read More

Published Date: NOV-2025 | No Of Pages:159 | $ 4485

Coagulation Factor Deficiency Market By Disease Type (Hemophilia A, Hemophilia B, Von Willebrand Disease); By Treatment Modality (Factor Replacement Therapy, Gene Therapy, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Region (North America, Europe, Asia-Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Coagulation Factor Deficiency Market is projected to grow at a 7.5% CAGR, rising from USD 11.5 billion in 2024 to USD 17.5 billion by 2030, driven by adva... Read More

Published Date: NOV-2025 | No Of Pages:193 | $ 4485

Bleeding Disorders Treatment Market By Product Type (Coagulation Factors, Gene Therapies, Others); By Disease Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Others); By End-User (Hospitals, Specialized Treatment Centers, CROs, Home Care Providers); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bleeding Disorders Treatment Market is projected to grow from USD 10.8 billion in 2024 to USD 14.9 billion by 2030, registering a CAGR of 5.6%, driven by ... Read More

Published Date: NOV-2025 | No Of Pages:156 | $ 4485

Hemophilia Gene Therapy Market By Therapy Type (AAV-Based Therapies, CRISPR-Based Therapies); By Hemophilia Type (Hemophilia A, Hemophilia B); By End User (Pharmaceutical & Biotech Companies, Healthcare Providers, CROs, Academic Institutions); By Region (North America, Europe, Asia-Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hemophilia Gene Therapy Market is valued at USD 4.1 billion in 2024 and is projected to reach USD 16.5 billion by 2030, registering a robust 25.6% CAGR, d... Read More

Published Date: NOV-2025 | No Of Pages:159 | $ 4485

Mantle Cell Lymphoma (MCL) Treatment Market By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Stem Cell Transplantation, Combination Therapy); By End-User (Hospitals & Clinics, Research Institutions, CROs, Academic & Community Oncology Practices); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Mantle Cell Lymphoma (MCL) Treatment Market is projected to grow from USD 5.3 billion in 2024 to USD 7.9 billion by 2030, at a robust 6.5% CAGR, driven by... Read More

Published Date: NOV-2025 | No Of Pages:168 | $ 4485

Pelvic Congestion Syndrome Treatment Market By Treatment Type (Minimally Invasive Procedures, Pharmacological Treatments, Surgical Treatments); By End User (Hospitals, Outpatient Clinics, Specialty Centers, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pelvic Congestion Syndrome (PCS) Treatment Market is expected to grow at a CAGR of 7.5% from 2024 to 2030, reaching USD 4.3 billion by 2030, up from Read More

Published Date: NOV-2025 | No Of Pages:164 | $ 4485

Cardiac Resynchronization Therapy Market By Product Type (CRT-P, CRT-D); By Application (Heart Failure with Reduced Ejection Fraction, Atrial Fibrillation, Post-Myocardial Infarction); By End User (Hospitals, Ambulatory Surgical Centers, Cardiologists & Clinics, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cardiac Resynchronization Therapy (CRT) Market is set to grow from USD 9.1 billion in 2024 to USD 14.5 billion by 2030, at a robust 8.2% CAGR, driven by rising heart failure prevalence, increasing ... Read More

Published Date: NOV-2025 | No Of Pages:198 | $ 4485

Stroke Rehabilitation Market By Rehabilitation Method (Physical Therapy, Occupational Therapy, Speech Therapy, Neurostimulation); By Product Type (Therapeutic Devices, Wearable Technology, Therapeutic Software, Others); By End-User (Hospitals and Rehabilitation Centers, Home Care Settings, CROs, Forensic and Environmental Labs); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Stroke Rehabilitation Market is set to witness substantial growth, projected to expand with a robust CAGR of 7.6% , valued at approximately $24.5 billion in 2024Read More

Published Date: NOV-2025 | No Of Pages:157 | $ 4485

Spinal Stenosis Market By Treatment Type (Surgical, Non-Surgical); By Type of Stenosis (Lumbar, Cervical, Thoracic); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Spinal Stenosis Market will expand at a compelling CAGR of 7.1% , valued at $7.4 billion in 2024 , and is projected to reach around $11.9 billion by 2030 ... Read More

Published Date: NOV-2025 | No Of Pages:156 | $ 4485

Human Chorionic Gonadotropin (hCG) Market By Product Type (Injectables, Oral, Test Kits); By Application (Fertility Treatments, Weight Management, Pregnancy Testing); By End User (Fertility Clinics, Pharmaceutical Companies, Diagnostic Laboratories, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Human Chorionic Gonadotropin (hCG) Market is projected to witness notable growth from 2024 to 2030, rising from USD 5.4 billion in 2024 to USD 8.74 billion by 2030 with a ... Read More

Published Date: NOV-2025 | No Of Pages:152 | $ 4485

Artificial Insemination Market By Methodology (Intrauterine Insemination, Intracervical Insemination, Intracytoplasmic Sperm Injection); By Application (Human Fertility, Animal Breeding); By End User (Fertility Clinics, Hospitals, Veterinary Clinics, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Artificial Insemination Market is expected to witness a steady growth trajectory in the coming years. Valued at USD 1.5 billion in 2024, it is projected to grow at a CAGR of 7.5%Read More

Published Date: NOV-2025 | No Of Pages:187 | $ 4485

Therapeutic Apheresis Market By Procedure Type (Plasmapheresis, Leukapheresis, Plateletpheresis, Erythrocytapheresis); By Application (Autoimmune Diseases, Neurological Disorders, Hematologic Disorders, Renal Disorders); By End User (Hospitals, Ambulatory Surgical Centers, Blood Donation Centers, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Therapeutic Apheresis Market is set to expand at a solid CAGR of 7.3%, valued at USD 3.2 billion in 2024 and projected to reach USD 5.3 billion by 2030, d... Read More

Published Date: NOV-2025 | No Of Pages:185 | $ 4485

Nerve Repair Market By Product Type (Nerve Grafts, Neurostimulation Devices, Stem Cell Therapies, Nerve Conduits, Others); By Application (Traumatic Nerve Injury, Neurodegenerative Diseases, Diabetic Neuropathy, Others); By End-User (Hospitals, Neurology Clinics, Research Institutes, CROs, Others); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Nerve Repair Market is set to grow at a CAGR of 8.6%, reaching USD 19.5 billion by 2030, up from USD 12.5 billion in 2024, according to Strategic ... Read More

Published Date: NOV-2025 | No Of Pages:190 | $ 4485

Gene Therapy Market By Vector Type (Viral Vectors [AAV, Lentivirus, Retrovirus], Non-Viral Vectors [Lipid Nanoparticles, Plasmids]); By Indication (Monogenic Disorders, Oncology, Ophthalmology, Neurology); By Delivery Method (In Vivo, Ex Vivo); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gene Therapy Market will witness a robust CAGR of 22.3%, valued at $12.4 billion in 2024, expected to appreciate and rea... Read More

Published Date: NOV-2025 | No Of Pages:198 | $ 4485

Viscosupplementation Market By Product Type (Single Injection, Multiple Injection, Combination Products); By End User (Orthopedic Clinics, Hospitals, Physiotherapy Centers); By Application (Knee Osteoarthritis, Hip Osteoarthritis, Other Joint Applications); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Viscosupplementation Market will experience steady growth over the forecast period from 2024 to 2030 , driven by increasing demand for minimally invasive ... Read More

Published Date: NOV-2025 | No Of Pages:171 | $ 4485

Arteriovenous Fistula Treatment Market By Treatment Type (Surgical AVF Creation, Percutaneous AVF Creation); By Surgical Method (End-to-End Anastomosis, Side-to-Side Anastomosis); By End User (Hospitals & Dialysis Centers, Outpatient Surgery Centers, Dialysis Clinics, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Arteriovenous Fistula (AVF) Treatment Market will experience significant growth during the forecast period from 2024 to 2030 , with a projected CAGR of 8.4Read More

Published Date: NOV-2025 | No Of Pages:194 | $ 4485